Crescent Capital BDC CCAP
Crescent Capital BDC Q1 FY26: net loss $15.5M; diluted EPS $0.42
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001193125-26-221936
Key figures from this report
These are the numbers Crescent Capital BDC reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Net income−$15.5M−497% from $3.9M in Q1 FY2510-Q income statement, on EDGAR
- Diluted EPS$0.42−7% from $0.45 in Q1 FY2510-Q income statement, on EDGAR
- Cash and cash equivalents$6.1M−49% from $12.0M in Q1 FY2510-Q balance sheet, on EDGAR
- Cash from operations−$23.8MAgainst −$15.1M in Q1 FY2510-Q cash flow statement, on EDGAR
